Table 3 Clinical outcomes of the patients studied
Variables | All patients (n = 152) | Intra-operative ECMO group (n = 81,53.3%) | Postoperative ECMO group (n = 71,46.7%) | P value |
|---|---|---|---|---|
Hospital mortality (n, %) | 104(68.4) | 47(58) | 57(80.3) | 0.003 |
On-ECMO mortality (n, %) | 74(48.7) | 31(38.3) | 43(60.6) | 0.006 |
ECMO weaning (n, %) | 78(51.32) | 50(61.73) | 28(39.44) | 0.002 |
Post-decannulation mortality (n, %) | 30(19.7) | 16(19.8) | 14(19.7) | 0.99 |
New need for CRRT | 72(47.4) | 26(32.1) | 46(64.8) | < 0.001 |
Limb ischemia (n, %) | 17(11.2) | 6(7.4) | 11(15.5) | 0.12 |
Bowel ischemia (n, %) | 6(3.9) | 2(2.5) | 4(5.6) | 0.42 |
Bowel surgery (n, %) | 1(0.7) | 0 | 1(1.4) | 0.47 |
Cerebrovascular stroke (n, %) | 28(18.4) | 9(11.1) | 19(26.8) | 0.013 |
Ischemic stroke (n, %) | 18(11.8) | 6(7.4) | 12(16.9) | 0.034 |
Cerebral bleeding (n, %) | 9(5.9) | 3(3.7) | 6(8.5) | 0.31 |
ECMO days | 6(3,10.5) | 6(3,11) | 6(3,10) | 0.94 |
ICU days | 17(7,32) | 14(7,31) | 19(7,38) | 0.38 |
SOFA-D3 | 14(10,17) | 12(9,15) | 16(13,18) | < 0.001 |
SOFA-D5 | 15(9,18) | 12(8,16) | 17(13,19) | < 0.001 |
SOFA(D3-1) | 2.5(2,3) | 2(2,3) | 3(2,3) | 0.15 |
SOFA(D5-3) | 1(− 1,2) | − 1(− 1,1) | 1(0,2) | 0.002 |
SOFA(D5-1) | 3(− 1,5) | 1(− 2,4) | 4(1,5) | 0.001 |
Post-ECMO durable LVAD (n, %) | 2(1.3) | 2(2.5) | 0 | 0.49 |
Post-ECMO heart transplantation (n, %) | 4(2.6) | 3(3.7) | 1(1.4) | 0.62 |